Details

Autor(en) / Beteiligte

• Roberts, A.
• James, J.
• Dhatariya, K.
• Agarwal, N.
• Brake, J.
• Brooks, C.
• Castro, E.
• Gregory, R.
• Higham, C.
• Hobley, L.
• Macklin, A.
• Roderick, W.
• Smith, F.
• Vanterpool, G.
• Winocour, P.
• Allan, B.
• Courtney, H.
• Flanagan, D.
• George, S.
• Kelly, T.
• Malik, R.
• Perry, C.
• Rayman, G.
• Ritchie, S.
• Sampson, M.
• Sinclair‐Hammersley, M.
• Stanisstreet, D.
• Valabhji, J.
• Walden, E.

Titel

Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group

Ist Teil von

• Diabetic medicine, 2018-08, Vol.35 (8), p.1011-1017

Ort / Verlag

England: Wiley Subscription Services, Inc

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Glucocorticoids (steroids) are widely used across many medical specialities for their anti‐inflammatory and immunosuppressive properties. However, one of their major side effects is the development of hyperglycaemia. It is well recognized that high glucose levels in people with diabetes in hospital are associated with harm and increased lengths of hospital stay. The use of glucocorticoid (steroid) treatment in people with pre‐existing diabetes will undoubtedly result in worsening glucose control, and this may be termed ‘steroid‐induced hyperglycaemia’, and will warrant temporary additional, and more active, glycaemic management. A rise in glucose may occur in people without a known diagnosis of diabetes, and this may be termed ‘steroid‐induced diabetes’. There is a lack of evidence to guide how people with hyperglycaemia should be managed, and much of the guidance given here is a consensus based on best practice collated from around the United Kingdom. Where evidence is available, this is referenced. These guidelines on the management of people with diabetes treated with steroids has been adapted specifically for Diabetic Medicine. The full version of the guidelines can be found on line at: www.diabetes.org.uk/joint-british-diabetes-society or https://abcd.care/joint-british-diabetes-societies-jbds-inpatient-care-group. What's new? This guideline aims to help in the management of hyperglycaemia in people given glucocorticoids as a hospital inpatient, and following discharge. The prevalence of steroid use in hospital inpatients may be in excess of 10%. There is a lack of evidence to guide how these people should be managed, and the guidance given here is a consensus based on best practice. The guideline suggests treatment algorithms and audit standards for benchmarking the management of steroid‐related hyperglycaemia.